Staff editor
We discussed the correlation between metabolic syndrome and synbiotic supplementation with Arrigo F. G. Cicero, professor at the University of Bologna and president of the Italian Society of Nutraceuticals.
Katayoun Welin Berger, BioGaia's Vice President Operations, tells us about the activities of the company.
The tumor microbiota could influence the pancreatic cancer survival, the 1st report to explore the effect of tumor bacteria on clinical outcomes claims.
"MIBIOC - The way of the microbiota in cancer" - IRCCS National Cancer Institute, Milan, 21-22th November 2019.
Imbalances of microbes, which are normally present on the skin, are one of the main subjects raised during the 24thCongress of Dermatology.
Rates of food allergy in children are spiking and it’s not certain why this increase in prevalence has occurred. The gut microbiome could play a role.
Find out how to be one of the 250+ microbiome leaders attending the definitive microbiome therapeutics meeting in Boston this June.
The relationship between bacteria and cancer is more and more investigated. We discuss it with Laurence Zitvogel, oncologist at the Institut Gustave Roussy.
Bacteria are critical in determining the outcome of surgical procedure. We talked about this with James Kinross from the Imperial College London.
The microbiome may be a source for biomarkers leading to therapeutic discoveries and diagnostics. We discuss it with Emily Hollister, Vice President of Diversigen.
